Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

(Mark One)

     
x
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2004
 
   
OR
   
 
   
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from                     to                    

Commission file number 1-14279


ORBITAL SCIENCES CORPORATION

(Exact name of registrant as specified in charter)
     
Delaware
(State of Incorporation of Registrant)
  06-1209561
(I.R.S. Employer Identification No.)

21839 Atlantic Boulevard
Dulles, Virginia 20166

(Address of principal executive offices)

(703) 406-5000
(Registrant’s telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  x No  o

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes  x No  o

     As of October 20, 2004, 51,569,774 shares of the registrant’s Common Stock were outstanding.

 


 

PART 1

FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

                 
    September 30,   December 31,
    2004
  2003
    (unaudited)        
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 119,663     $ 60,900  
Restricted cash and cash equivalents
    13,675       19,258  
Receivables, net
    146,773       149,508  
Inventories, net
    11,872       12,642  
Other current assets
    5,921       5,496  
 
   
 
     
 
 
Total current assets
    297,904       247,804  
 
   
 
     
 
 
Property, plant and equipment, net
    79,988       82,364  
Goodwill
    95,293       95,293  
Other non-current assets
    11,875       13,839  
 
   
 
     
 
 
Total assets
  $ 485,060     $ 439,300  
 
   
 
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Current portion of long-term obligations
  $ 217     $ 297  
Accounts payable and accrued expenses
    128,539       116,026  
Deferred revenues
    16,536       16,292  
 
   
 
     
 
 
Total current liabilities
    145,292       132,615  
 
   
 
     
 
 
Long-term obligations, net of current portion
    127,667       137,116  
Other non-current liabilities
    1,457       2,692  
Commitments and contingencies
               
Stockholders’ equity:
               
Preferred Stock, par value $.01; 10,000,000 shares authorized, none outstanding
           
Common Stock, par value $.01; 200,000,000 shares authorized, 51,564,249 and 48,072,580 shares outstanding, respectively
    516       480  
Additional paid-in capital
    600,908       591,482  
Deferred compensation
    (138 )     (502 )
Accumulated deficit
    (390,642 )     (424,583 )
 
   
 
     
 
 
Total stockholders’ equity
    210,644       166,877  
 
   
 
     
 
 
Total liabilities and stockholders’ equity
  $ 485,060     $ 439,300  
 
   
 
     
 
 

See accompanying notes to condensed consolidated financial statements.

1


 

ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share data)

                 
    For the Quarters Ended
    September 30,
    2004
  2003
    (unaudited)   (unaudited)
Revenues
  $ 171,695     $ 128,629  
Costs of goods sold
    142,458       101,736  
 
   
 
     
 
 
Gross profit
    29,237       26,893  
Research and development expenses
    1,457       2,332  
Selling, general and administrative expenses
    13,457       14,250  
Settlement expense
          (913 )
 
   
 
     
 
 
Income from operations
    14,323       11,224  
Interest expense
    (2,847 )     (3,544 )
Other income, net
    521       931  
Debt extinguishment expense
    (577 )     (38,836 )
 
   
 
     
 
 
Income (loss) before provision for income taxes
    11,420       (30,225 )
Provision for income taxes
    (25 )      
 
   
 
     
 
 
Net income (loss)
  $ 11,395     $ (30,225 )
 
   
 
     
 
 
Basic net income (loss) per share
  $ 0.23     $ (0.64 )
 
   
 
     
 
 
Diluted net income (loss) per share
  $ 0.18     $ (0.64 )
 
   
 
     
 
 

See accompanying notes to condensed consolidated financial statements.

2


 

ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share data)

                 
    For the Nine Months Ended
    September 30,
    2004
  2003
    (unaudited)   (unaudited)
Revenues
  $ 500,751     $ 423,710  
Costs of goods sold
    416,946       349,089  
 
   
 
     
 
 
Gross profit
    83,805       74,621  
Research and development expenses
    4,654       5,230  
Selling, general and administrative expenses
    38,653       43,743  
Settlement expense
    (2,538 )     3,587  
 
   
 
     
 
 
Income from operations
    43,036       22,061  
Interest expense
    (8,645 )     (15,768 )
Other income, net
    1,174       1,127  
Debt extinguishment expense
    (1,138 )     (38,836 )
 
   
 
     
 
 
Income (loss) before provision for income taxes
    34,427       (31,416 )
Provision for income taxes
    (486 )      
 
   
 
     
 
 
Net income (loss)
  $ 33,941     $ (31,416 )
 
   
 
     
 
 
Basic net income (loss) per share
  $ 0.69     $ (0.68 )
 
   
 
     
 
 
Diluted net income (loss) per share
  $ 0.52     $ (0.68 )
 
   
 
     
 
 

See accompanying notes to condensed consolidated financial statements.

3


 

ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

                 
    For the Nine Months Ended
    September 30,
    2004
  2003
    (unaudited)   (unaudited)
Cash Flows From Operating Activities:        
Net income (loss)
  $ 33,941     $ (31,416 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Depreciation and amortization
    10,966       11,721  
Amortization of debt issuance costs and debt discount
    665       3,837  
Stock-based compensation and contributions to defined contribution plan
    (374 )     6,811  
Debt extinguishment expense
    1,138       38,836  
Changes in assets and liabilities and other
    14,852       3,403  
 
   
 
     
 
 
Net cash provided by operating activities
    61,188       33,192  
 
   
 
     
 
 
Cash Flows From Investing Activities:
               
Capital expenditures
    (8,562 )     (5,351 )
Escrow proceeds related to former business disposition
          3,000  
Change in cash restricted for letters of credit, net
    5,581       (9,016 )
 
   
 
     
 
 
Net cash used in investing activities
    (2,981 )     (11,367 )
 
   
 
     
 
 
Cash Flows From Financing Activities:
               
Payments on long-term obligations
    (9,672 )     (144,355 )
Net proceeds from issuances of long-term obligations
          129,046  
Repurchase of common stock
    (7,000 )      
Net proceeds from issuances of common stock
    17,228       3,463  
 
   
 
     
 
 
Net cash provided by (used in) financing activities
    556       (11,846 )
 
   
 
     
 
 
Net increase in cash and cash equivalents
    58,763       9,979  
Cash and cash equivalents, beginning of period
    60,900       43,440  
 
   
 
     
 
 
Cash and cash equivalents, end of period
  $ 119,663     $ 53,419  
 
   
 
     
 
 

See accompanying notes to condensed consolidated financial statements.

4


 

ORBITAL SCIENCES CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004 and 2003
(Unaudited)

(1)   Basis of Presentation

     Orbital Sciences Corporation (together with its subsidiaries, “Orbital” or the “company”), a Delaware corporation, develops and manufactures small space and rocket systems for commercial, military and civil government customers. The company’s primary products are satellites and launch vehicles, including low-orbit, geosynchronous and planetary spacecraft for communications, remote sensing, scientific and defense missions; ground- and air-launched rockets that deliver satellites into orbit; and missile defense systems that are used as interceptor and target vehicles. Orbital also offers space-related technical services to government agencies and develops and builds satellite-based transportation management systems for public transit agencies and private vehicle fleet operators.

     In the opinion of management, the accompanying unaudited interim financial information reflects all adjustments, consisting of normal recurring accruals, necessary for a fair presentation on a going concern basis. Certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the Securities and Exchange Commission. The company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited interim condensed consolidated financial statements are read in conjunction with the audited consolidated financial statements contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2003, as amended.

     Operating results for the quarter and nine months ended September 30, 2004 are not necessarily indicative of the results expected for the full year.

(2)   Preparation of Condensed Consolidated Financial Statements

     The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions, including estimates of future contract costs and earnings. Such estimates and assumptions affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and earnings during the current reporting period. Management periodically assesses and evaluates the adequacy and/or deficiency of estimated liabilities recorded for various reserves, liabilities, contract risks and uncertainties. Actual results could differ from these estimates.

     All financial amounts are stated in U.S. dollars unless otherwise indicated.

5


 

(3)   Stock-Based Compensation

     Statement of Financial Accounting Standards (“SFAS”) No. 123, “Accounting for Stock-Based Compensation,” as amended by SFAS No. 148, “Accounting for Stock-Based Compensation — Transition and Disclosure, an amendment of FASB Statement No. 123,” requires companies to (i) recognize as expense the fair value of stock-based awards, or (ii) continue to apply the provisions of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” and related interpretations (“APB 25”), and provide pro forma net income and earnings per share disclosures for employee stock option grants as if the fair-value-based method defined in SFAS No. 123 had been applied. The company continues to apply the provisions of APB 25 and provide the pro forma disclosures in accordance with the provisions of SFAS Nos. 123 and 148. Under APB 25, the company has not recorded any stock-based employee compensation cost associated with the company’s stock option plan, as all options granted under the plan had an exercise price equal to the market value of the underlying common stock on the date of grant.

     The company uses the Black-Scholes option-pricing model to determine the pro forma impact under SFAS Nos. 123 and 148 on the company’s net income and earnings per share. The model utilizes certain information, such as the interest rate on a risk-free security maturing generally at the same time as the option being valued, and requires certain assumptions, such as the expected amount of time an option will be outstanding until it is exercised or it expires, to calculate the fair value of stock options granted. This information and the assumptions used for the quarter and nine-month periods ended September 30, 2004 and 2003 are summarized as follows:

                 
    Quarters Ended September 30,
    2004
  2003
Additional shares authorized for grant at September 30
    421,836       1,455,181  
Volatility
    65 %     66 %
Risk-free interest rate
    2.88 %     2.44 %
Weighted-average fair value per share at grant date
  $ 4.94     $ 4.83  
Expected dividend yield
           
Expected life of options (years)
    2.5       4.5  
                 
    Nine Months Ended September 30,
    2004
  2003
Additional shares authorized for grant at September 30
    421,836       1,455,181  
Volatility
    65 %     66 %
Risk-free interest rate
    3.06 %     1.69 %
Weighted-average fair value per share at grant date
  $ 3.96     $ 3.35  
Expected dividend yield
           
Expected life of options (years)
    2.5 – 4.5       4.5  

6


 

     The following table illustrates the effect on net income (loss) and earnings (loss) per share if the company had applied the fair value recognition provisions of SFAS No. 123 to its stock option plan (in thousands, except per share amounts):

                 
    Quarters Ended September 30,
    2004
  2003
Net income (loss), as reported
  $ 11,395     $ (30,225 )
Stock-based employee compensation expense per fair-value-based method
    (1,378 )     (1,374 )
 
   
 
     
 
 
Pro forma net income (loss)
  $ 10,017     $ (31,599 )
 
   
 
     
 
 
Earnings (loss) per share:
               
Basic—as reported
  $ 0.23     $ (0.64 )
Basic—pro forma
  $ 0.20     $ (0.67 )
Diluted—as reported
  $ 0.18     $ (0.64 )
Diluted—pro forma
  $ 0.15     $ (0.67 )
                 
    Nine Months Ended September 30,
    2004
  2003
Net income (loss), as reported
  $ 33,941     $ (31,416 )
Stock-based employee compensation expense per fair-value-based method
    (5,416 )     (3,184 )
 
   
 
     
 
 
Pro forma net income (loss)
  $ 28,525     $ (34,600 )
 
   
 
     
 
 
Earnings (loss) per share:
               
Basic—as reported
  $ 0.69     $ (0.68 )
Basic—pro forma
  $ 0.58     $ (0.74 )
Diluted—as reported
  $ 0.52     $ (0.68 )
Diluted—pro forma
  $ 0.44     $ (0.74 )

     Pro forma net income (loss) reflects only options granted through September 30, 2004 and, therefore, may not be representative of the effects for future periods.

(4)   Industry Segment Information

     Orbital’s space-related products and services are grouped into three reportable segments: (i) launch vehicles (formerly launch vehicles and advanced programs), (ii) satellites and related space systems and (iii) transportation management systems. Reportable segments are generally organized based upon product lines. Corporate and other is comprised of the elimination of intercompany revenues and certain corporate items that have not been attributed to a particular segment.

     Intersegment sales are generally negotiated and accounted for under terms and conditions that are similar to other commercial and government contracts. Intersegment sales of $2.1 million and $1.9 million were recorded in the quarters ended September 30, 2004 and 2003, respectively. Intersegment sales of $6.6 million and $5.1 million were recorded in the nine months ended September 30, 2004 and 2003, respectively.

     The following table presents operating information for the quarters and nine months ended September 30, 2004 and 2003 and identifiable assets at September 30, 2004 and December 31, 2003 by reportable segment (in thousands).

7


 

                                 
    Quarters Ended September 30,
  Nine Months Ended September 30,
    2004
  2003
  2004
  2003
Launch Vehicles:
                               
Revenues
  $ 80,153     $ 78,368     $ 243,150     $ 244,073  
Operating income
    8,065       7,482       22,188       25,261  
Identifiable assets
    119,146       126,960 (1)     119,146       126,960 (1)
Capital expenditures
    1,132       418       2,725       2,546  
Depreciation and amortization
    1,300       1,326       3,930       4,251  
Satellites and Related Space Systems:
                               
Revenues
  $ 86,551     $ 40,471     $ 241,755     $ 157,860  
Operating income
    5,956       2,768       17,390       8,619  
Identifiable assets
    166,692       149,933 (1)     166,692       149,933 (1)
Capital expenditures
    1,961       673       4,623       1,417  
Depreciation and amortization
    1,327       1,433       3,895       4,301  
Transportation Management Systems:
                               
Revenues
  $ 7,096     $ 11,642     $ 22,411     $ 26,846  
Operating income (loss)
    302       359       920       (7,934 )
Identifiable assets
    24,383       37,596 (1)     24,383       37,596 (1)
Capital expenditures
    12       34       160       238  
Depreciation and amortization
    177       207       560       600  
Corporate and Other:
                               
Revenues
  $ (2,105 )   $ (1,852 )   $ (6,565 )   $ (5,069 )
Operating income (loss)
          615       2,538       (3,885 )
Identifiable assets
    174,839       124,811 (1)     174,839       124,811 (1)
Capital expenditures
    305       59       1,054       1,150  
Depreciation and amortization
    858       821       2,581       2,569  
Consolidated:
                               
Revenues
  $ 171,695     $ 128,629     $ 500,751     $ 423,710  
Operating income
    14,323       11,224       43,036       22,061  
Identifiable assets
    485,060       439,300 (1)     485,060       439,300 (1)
Capital expenditures
    3,410       1,184       8,562       5,351  
Depreciation and amortization
    3,662       3,787       10,966       11,721  

(1)   As of December 31, 2003

(5)   Receivables

     Receivables consisted of the following (in thousands):

                 
    September 30, 2004
  December 31, 2003
Billed
  $ 40,322     $ 55,812  
Unbilled
    106,620       93,883  
Allowance for doubtful accounts
    (169 )     (187 )
 
   
 
     
 
 
Total
  $ 146,773     $ 149,508  
 
   
 
     
 
 

8


 

(6)   Inventories

     Inventories consisted of the following (in thousands):

                 
    September 30, 2004
  December 31, 2003
Inventories
  $ 14,740     $ 15,475  
Allowance for inventory obsolescence
    (2,868 )     (2,833 )
 
   
 
     
 
 
Total
  $ 11,872     $ 12,642  
 
   
 
     
 
 

     Substantially all of the company’s inventory consisted of component parts and raw materials.

(7)   Warranties

     The company assumes warranty obligations in connection with certain contracts. The company records a liability for estimated warranty claims based upon historical data and customer information. Activity in the warranty liability consisted of the following (in thousands):

                 
    Quarter Ended   Quarter Ended
    September 30, 2004
  September 30, 2003
Balance at beginning of period
  $ 4,340     $ 4,768  
Accruals during the period
    318       372  
Reductions during the period
    (1,118 )     (227 )
 
   
 
     
 
 
Balance at end of period
  $ 3,540     $ 4,913  
 
   
 
     
 
 
                 
    Nine Months Ended   Nine Months Ended
    September 30, 2004
  September 30, 2003
Balance at beginning of period
  $ 5,020     $ 4,554  
Accruals during the period
    656       1,298  
Reductions during the period
    (2,136 )     (939 )
 
   
 
     
 
 
Balance at end of period
  $ 3,540     $ 4,913  
 
   
 
     
 
 

(8)   Interest Expense

     Interest expense consisted of the following (in thousands):

                                 
    Quarters Ended   Nine Months Ended
    September 30,
  September 30,
    2004
  2003
  2004
  2003
Interest
  $ 2,649     $ 3,334     $ 7,980     $ 11,931  
Amortization of debt issuance costs
    198       210       665       1,622  
Amortization of debt discount
                      2,215  
 
   
 
     
 
     
 
     
 
 
Total
  $ 2,847     $ 3,544     $ 8,645     $ 15,768  
 
   
 
     
 
     
 
     
 
 

9


 

(9)   Earnings (Loss) Per Share

     The following table presents the shares used in computing basic and diluted earnings per share (“EPS”) (in thousands):

                 
    Quarter Ended   Quarter Ended
    September 30, 2004
  September 30, 2003
Weighted average of outstanding shares for basic EPS
    50,358       47,377  
Dilutive effect of outstanding stock options and warrants
    14,400        
 
   
 
     
 
 
Shares for diluted EPS
    64,758       47,377  
 
   
 
     
 
 
 
    Nine Months Ended   Nine Months Ended
    September 30, 2004
  September 30, 2003
Weighted average of outstanding shares for basic EPS
    49,060       46,512  
Dilutive effect of outstanding stock options and warrants
    16,203        
 
   
 
     
 
 
Shares for diluted EPS
    65,263       46,512  
 
   
 
     
 
 

     In periods of losses from operations, such as the quarter and nine months ended September 30, 2003, diluted per-share losses are the same as basic per-share losses because the effect of stock options and warrants would be anti-dilutive.

(10)   Comprehensive Income (Loss)

     Comprehensive income (loss) in the quarter and nine-month periods ended September 30, 2004 and 2003 was equal to net income (loss). Accumulated other comprehensive income (loss) as of September 30, 2004 and December 31, 2003 was $0.

(11)   Sale of ORBIMAGE Notes

     On December 31, 2003, Orbital received $2.5 million of senior subordinated notes due 2008 from its former affiliate, Orbital Imaging Corporation (“ORBIMAGE”), upon the consummation of ORBIMAGE’s plan of reorganization. In 2003, Orbital recorded $4.8 million of charges, including $4.5 million in the first nine months of 2003, in connection with a settlement agreement with ORBIMAGE. In the first quarter of 2004, the company sold the notes to a financial institution and recorded a $2.5 million gain on this transaction as a credit to settlement expense. Orbital does not have any equity or debt investment in ORBIMAGE’s successor company.

(12)   Debt

     The following table sets forth the company’s long-term obligations, excluding capital lease obligations (in thousands):

                 
    September 30, 2004
  December 31, 2003
9% senior notes, interest due semi-annually, principal due in July 2011
  $ 126,425     $ 135,000  
Interest rate swap fair value hedge adjustment on $50 million of 9% Senior Notes
    1,115       1,847  
 
   
 
     
 
 
 
    127,540       136,847  
Less current portion
           
 
   
 
     
 
 
Long-term portion
  $ 127,540     $ 136,847  
 
   
 
     
 
 

10


 

     During the first nine months of 2004, the company repurchased and cancelled $8.6 million of its 9% senior notes at a cost of $9.6 million under a securities repurchase program. The company recorded $1.1 million in debt extinguishment expense during the nine months ended September 30, 2004 associated with the repurchases.

     The fair value of the company’s senior notes at September 30, 2004 and December 31, 2003 was estimated at $141.0 million and $145.1 million, respectively, based on market trading activity.

     The company has a $50.0 million four-year revolving credit facility (the “Revolver”) with Bank of America serving as the lead arranger in a syndicated line of credit. The Revolver bears interest at rates ranging from 2.25% to 3.0% over LIBOR (for LIBOR loans) or from 0.75% to 1.5% over a base rate related to the prime rate (for base rate loans), varying according to the company’s ratio of total debt to earnings before interest, taxes, depreciation and amortization. The Revolver is collateralized by substantially all of the company’s assets. The Revolver also permits the company to reserve up to $40.0 million of the facility for letters of credit, foreign exchange contracts or other arrangements. The maximum borrowing capacity under the Revolver is limited by a borrowing base formula that is tied to the company&